Become Innovation Ambassador as a SMT Gold Sponsor

Reminder: Confirm Medtech Innovation Ambassador Commitment by email to info@innofuse.swiss

## **You have saved your seat to become a Medtech Innovation Ambassador! Please confirm your commitment by sending an email to [info@innofuse.swiss](mailto:info@innofuse.swiss) - Call Open till the 30st of September 2025.**

As a SMT Gold Sponsor you are belonging to the early movers and by supporting Swiss Medtech (SMT) as an Innovation Ambassador your organization will grant access to all 800+ Swiss Medtech Members to the new SMT Innovation Platform – imagine the collective innovation power once the ecosystem is connected with a highly efficient tool which matchmakes expertise to connect great minds.

You will change the way how interdisciplinary innovation will naturally happen across the country.

**Your Benefits**
As an early mover you will gain 
* Priority access to the SMT Innovation Platform
* Visibility on the platform as Gold Sponsor, and social media communication
* As long you remain SMT Gold Sponsor and Innovation Ambassador, your organization will profit from an unlimitted annual licenses to the platform. This special conditions will remain lifelong.
Be seen as the facilitator and position your company as Innovation Ambassador in the sector.

**Ticket:** 20’000 CHF / year 

Fill out this form to register

## **Thank you for your interest in becoming a Swiss Medtech Innovation Ambassador!**

As a SMT Gold Sponsor you are belonging to the early movers and by supporting Swiss Medtech (SMT) as an Innovation Ambassador your organization will grant access to all 800+ Swiss Medtech Members to the new SMT Innovation Platform – imagine the collective innovation power once the ecosystem is connected with a highly efficient tool which matchmakes expertise to connect great minds.

You will change the way how interdisciplinary innovation will naturally happen across the country.

**Your Benefits**

As an early mover you will gain 
* Priority access to the SMT Innovation Platform
* Visibility on the platform as Gold Sponsor, and social media communication
* As long you remain SMT Gold Sponsor and Innovation Ambassador, your organization will profit from an unlimitted annual licenses to the platform. This special conditions will remain lifelong.
Be seen as the facilitator and position your company as Innovation Ambassador in the sector.

**Ticket:** 20’000 CHF / year

large_Banner_SMT-Innofuse.png

medium_Banner_SMT-Innofuse.png

small_Banner_SMT-Innofuse.png

thumbnail_Banner_SMT-Innofuse.png

Become SMT Gold Sponsor

Innovation Ambassadors - SMT Gold Sponsor

Pre-Registration for the SMT Innovation Platform

Reminder: Finish Pre-Registration to SMT Innovation Platform

## Pre-Registration for the SMT Innovation Platform
We are thrilled to announce the opportunity for you to pre-register for access to the SMT Innovation Platform, an initiative by the Swiss Medtech Association in colaboration with Innofuse. By pre-registering, you will secure your place among the first users to explore this innovative platform designed to enhance collaboration, knowledge sharing within the community. 

### Benefits of Pre-Registration:
- **Priority Notification:** Be the first to know when the SMT Innovation Platform is live and ready for exploration.
- **Access to the Innofuse Ecosystem:** After filling out your registration [here](https://innofuse.swiss/products/professional?offerId=710c15ce-d741-4670-aaaa-ecd6285c1f8c), until the SMT Innovation Platform is online. The Innofuse team will contact you as soon your access is ready, latest end of July 2025.

### How to Pre-Register:
- **Fill out the registration form:** Fill out [this form](https://innofuse.swiss/products/professional?offerId=710c15ce-d741-4670-aaaa-ecd6285c1f8c),
- **Confirmation:** You will receive a confirmation email acknowledging your pre-registration.
- **Stay Tuned:** You will receive an access notification once the platform is launched, we will notify you via email with instructions on how to access it.

Please be informed that as a Swiss Medtech Association Member, your organization will receive three free licenses. You can also register as a non-member of SMT, and we will get in touch with you regarding license access.

Thank you for your interest in the SMT Innovation Platform. We look forward to having you join us on this exciting journey!

## Pre-Registration for the SMT Innovation Platform
We are thrilled to announce the opportunity for you to pre-register for access to the SMT Innovation Platform, an initiative by the Swiss Medtech Association in colaboration with Innofuse. By pre-registering, you will secure your place among the first users to explore this innovative platform designed to enhance collaboration, knowledge sharing within the community. 

### Benefits of Pre-Registration:
- **Priority Notification:** Be the first to know when the SMT Innovation Platform is live and ready for exploration.
- **Access to the Innofuse Ecosystem:** After filling out your registration, until the SMT Innovation Platform is online.

### How to Pre-Register:
- **Fill out this form:** Fill out your name and email address to express your interest.
- **Confirmation:** You will receive a confirmation email acknowledging your pre-registration.
- **Stay Tuned:** You will receive an access notification once the platform is launched, we will notify you via email with instructions on how to access it.

Please be informed that as a Swiss Medtech Association Member, your organization will receive three free licenses. You can also register as a non-member of SMT, and we will get in touch with you regarding license access.

Thank you for your interest in the SMT Innovation Platform. We look forward to having you join us on this exciting journey!

large_Swiss-Medtech-Platform-Launch.jpg

medium_Swiss-Medtech-Platform-Launch.jpg

small_Swiss-Medtech-Platform-Launch.jpg

thumbnail_Swiss-Medtech-Platform-Launch.jpg

Get early-access to the SMT Innovation Platform

Pre-Registration - SMT Innovation Platform

_Bern, Switzerland – June 25, 2025_– At today’s Swiss Medtech Day in Bern, Swiss Medtech and Innofuse Switzerland officially unveiled a strategic partnership aimed at accelerating innovation across the Swiss medical technology sector. Together, they are launching the **Swiss Medtech Innovation Platform** - a new digital matchmaking ecosystem designed to connect innovators, catalyze partnerships, and foster legally secure collaboration within the Medtech industry.

Swiss Medtech will provide all its member companies with access to the platform. While not exclusive to the association, members will be among the first to benefit. The platform is currently in development and set to launch in October 2025. 

“With the Swiss Medtech Innovation Platform, we’re creating a national engine for innovation,” said **Dr. Daniel Delfosse Vice Director of Swiss Medtech**. “By joining forces with Innofuse, we’re offering our members an unprecedented tool to discover collaborators - also outside the Medtech industry, across all sectors - , co-develop solutions, and stay ahead in a competitive global market.”

At the heart of the platform is a smart matchmaking algorithm that intelligently connects companies, startups, researchers, and clinical experts based on their innovation needs, technological strengths, and strategic focus areas. All collaboration is facilitated within a secure, compliant framework - ensuring both agility and peace of mind for participants.

The founding team of Innofuse Switzerland brings deep roots in Medtech entrepreneurship and innovation management. “This platform is about more than networking - it's about enabling real innovation, faster and create the missing visibility,” said **Ivan Sanicola, CEO and Co-Founder of Innofuse Switzerland**. “We’re proud to be building this together with Swiss Medtech and its community of pioneers.”

Swiss Medtech and Innofuse invite the broader ecosystem to contribute to shaping the platform in the coming months, ensuring it meets the evolving needs of the Swiss Medtech landscape.

**About Swiss Medtech**

Swiss Medtech represents over 800 companies in its role as industry association for medical technology in Switzerland. With the third-highest contribution to Switzerland’s trade surplus and a workforce of over 70,000, the Medtech sector contributes significantly to the domestic economy. Swiss Medtech advocates for conditions that enable the industry to achieve peak performance and provide first-class medical care. 

**About Innofuse Switzerland**

Innofuse Switzerland is a matchmaking and innovation company focused on creating structured, high-impact collaboration. Built by experienced industry professionals, Innofuse develops tools and the platform that connect the right minds to solve tomorrow’s healthcare challenges.


large_SMT Day 2025_Publication.JPG

medium_SMT Day 2025_Publication.JPG

small_SMT Day 2025_Publication.JPG

thumbnail_SMT Day 2025_Publication.JPG

Official announcement at Swiss MEDTECH Day 2025 in Bern marks bold new direction for Medtech collaboration in Switzerland

Swiss MEDTECH and Innofuse Switzerland Join Forces to Launch National Innovation Platform

Join our Honest Talk about ICT Startup Ecosystem Basel

Honest Talk by Innofuse: ICT Startup Ecosystem Basel

You successfully registered for our event

# Honest Talk on ICT Startup Ecosystem Basel: Road Blocker Breaker – Acceleration Hacks – Future Basel ICT Community
* **Date:** 11th June 2025 | Time: 17:15 - 20:00
* **Location:** Innofuse, @ORBIZ Basel, Aeschengraben 9, 4051 Basel
* **Objective:** Join us for an insightful and collaborative session where we address current ICT startup challenges, brainstorm effective hacks, and build relationships for the future. This interactive event is designed to foster open dialogue and problem-solving, bringing together experienced startups, entrepreneurs, and interested industry professionals to tackle the hurdles of ICT startups in the Basel Area and build the future of the ecosystem.
#### Event Highlights
* Freshly backed announcements – be curious 😊
* Honest Talks Breakout Sessions with experienced startup peers – learn, share, and create the future of the Basel ICT ecosystem
* Dive into three key topics
* Networking event for real, field-tested ICT startups – shake hands with the creators of tomorrow
* Collaboration: Participate in a team-based brainstorming session with other ICT startups to identify practical solutions and push your idea forward
* Gain access to ICT communities of practice that go beyond the event and remain active even afterward 
#### Speakers
Will be published soon…
#### Why Attend?
This is your chance to collaborate with peers, share insights, and find actionable solutions to common challenges in the ICT startup ecosystem industry. Don’t miss out on the opportunity to connect, learn, and drive meaningful change!

**The event is free of charge -  limited seat available - registration mandatory.**

**Featured by the Startup Academy, the innovation promotion department canton of Basel City and Innofuse Switzerland.**

**Location Sponsor: ORBIZ Aeschengraben Basel**

Fill out this form to join our event

# Honest Talk on ICT Startup Ecosystem Basel: Road Blocker Breaker – Acceleration Hacks – Future Basel ICT Community
* **Date:** 11th June 2025 | Time: 17:15 - 20:00
* **Location:** Innofuse, @ORBIZ Basel, Aeschengraben 9, 4051 Basel
* **Objective:** Join us for an insightful and collaborative session where we address current ICT startup challenges, brainstorm effective hacks, and build relationships for the future. This interactive event is designed to foster open dialogue and problem-solving, bringing together experienced startups, entrepreneurs, and interested industry professionals to tackle the hurdles of ICT startups in the Basel Area and build the future of the ecosystem.
#### Event Highlights
* Freshly backed announcements – be curious 😊
* Honest Talks Breakout Sessions with experienced startup peers – learn, share, and create the future of the Basel ICT ecosystem
* Dive into three key topics
* Networking event for real, field-tested ICT startups – shake hands with the creators of tomorrow
* Collaboration: Participate in a team-based brainstorming session with other ICT startups to identify practical solutions and push your idea forward
* Gain access to ICT communities of practice that go beyond the event and remain active even afterward 
#### Speakers
Will be published soon…
#### Why Attend?
This is your chance to collaborate with peers, share insights, and find actionable solutions to common challenges in the ICT startup ecosystem industry. Don’t miss out on the opportunity to connect, learn, and drive meaningful change!

**The event is free of charge -  limited seat available - registration mandatory.**

**Featured by the Startup Academy, the innovation promotion department canton of Basel City and Innofuse Switzerland.**

**Location Sponsor: ORBIZ Aeschengraben Basel**


large_Innofuse Orbiz November 2024_086.jpg

medium_Innofuse Orbiz November 2024_086.jpg

small_Innofuse Orbiz November 2024_086.jpg

thumbnail_Innofuse Orbiz November 2024_086.jpg

Road Blocker Breaker – Acceleration Hacks – Future Basel ICT Community

Honest Talk on ICT Startup Ecosystem Basel

# **🚨 Honest Talk about PFAS in the Medical Devices Industry – How Is the Industry Responding?**

First, the good news: you can find bellow our summary for free – because collective expertise should be shared, not siloed. Especially here in Switzerland, collaboration drives progress.

✅ Last week, we hosted the first-ever “Honest Talk” event co-hosted by Swiss Medtech, gathering experts across the industry to tackle one of our most pressing topics: PFAS regulations.

We asked: 
🔍 What urgent steps must the MEDTECH industry take?
 ⚖️ How can we stay compliant and pragmatic?
 ❓ What’s still unclear – and when will we know more?

With new regulations from ECHA and EPA, the pressure is real. But the mindset was clear: solutions over fear. 💡

📝 Based on the discussion, Innofuse created a free one-pager with actionable insights. Want a copy? Drop us a message on info@innofuse.swiss, and we’ll send it your way.

📢 Bonus: A new Community of Practice (CoP) is launching on the Innofuse platform – open to all – for ongoing exchange, events, and learning around PFAS and regulatory challenges. Link to the CoP: [Link](https://platform.innofuse.swiss/initiatives/0ee330e7-baaf-4268-859b-211a34f66087)

Let’s keep the momentum going. 

Big thanks to Dr. Werner Schneider & Dr. Philippe Hasgall by Zimmer Biomet, Prof. Dr. Marco Rupprich by Hochschule für Life Sciences FHNW, Bernhard Pultar by POC APP AG, and to all our engaged participants from Camlog, Medartis, Alcon, Metecon Schweiz GmbH, and Swiss Medtech.

#PFAS #Medtech #HonestTalk #MedicalDevices #Innofuse #SwissMEDTECH #CommunityOfPractice #Regulations


# **Summary: Honest Talk by Innofuse - CMR-PFAS - 24th April 2025**

**1.	CMR and PFAS in the Medical Device Industry – Key Takeaways**

Lecture by Werner Schneider, Zimmer Biomet
**Use of PFAS**

•	PFAS are utilized due to their unique properties: chemical resistance, biocompatibility, inertness, flame resistance, and low specific weight.

•	PFAS are ubiquitous. Any substance containing fluorine should be verified against regulatory lists (e.g., CAS, POP).

**Health and Environmental Concerns**

•	Although PFAS are not inherently dangerous, their long-term accumulation is persistent, bio accumulative, toxic, and mobile.

•	Experiments with zebrafish (Zebrafish experiments) have shown PFAS can have endocrine-disrupting effects.

**Handling PFAS**

•	Upon identification of PFAS, objectives are to replace them, minimize usage (with annual reporting for derogated uses), and control emissions.

•	Exception lists exist for substances without viable alternatives.

**Regulatory Compliance and Challenges**

•	The medical device industry faces a complex web of environmental regulations, making compliance extremely difficult and at times seemingly "unmanageable."

•	Relevant regulations include REACH, RoHS, CLP, EU MDR, POP, BPR, PFAS-specific regulations, CA Prop 65, and TSCA (U.S. REACH equivalent).

•	Manufacturers must maintain Material Safety Data Sheets (MSDS).

•	CAS numbers should be centrally stored and monitored to track newly regulated substances.

**Life Cycle Assessment**

•	Effective life cycle management requires controlling the chemical supply chain, from raw materials through design, production, transportation, use, and end-of-life disposal.

•	Relevant standards: ISO 14040 and ISO 14044.

**Insurance and Supply Chain Risks**

•	Insurance companies are increasingly withdrawing coverage from companies handling PFAS, with some U.S. insurers cancelling policies immediately.

•	Major suppliers like 3M plan to phase out all PFAS-containing products by the end of 2025 (3M will completely phase out PFAS), causing supply chain disruptions as key substances become unavailable.

•	These disruptions could impact processes, batch production, and overall material availability.

**2.	Summary of Most Challenging Topics Regarding CMR/PFAS**

**Materials**

•	Identifying which materials, from patient-contact substances to auxiliary materials, contain CMR (Carcinogenic, Mutagenic, or toxic for Reproduction) substances.

**Supplier and Supply Chain Management**

•	Managing suppliers who often lack awareness or understanding of CMR and PFAS substances.

**EO Sterilization and Processes**

•	Understanding the role of CMR substances in Ethylene Oxide (EO) sterilization processes and exploring possible alternatives.
Lack of Knowledge, Expertise, and Support:

•	There is a strong need for accessible expertise and guidance to navigate the complexities surrounding CMR and PFAS management and regulation.

**3.	 Summary of Brainstorming on Supplier and Supply Chain Management**

**Key Concerns**

•	Source Identification: Determining where PFAS enter the supply chain remains a critical issue.

•	Process and Product Analysis: Identifying processes and materials (e.g., detergents) potentially impacted by PFAS restrictions. Analysing whether PFAS are present in final products to assess business risks.

**Strategic Supplier Engagement**

•	Considering collective action through industry associations like Swiss Medtech or MedTech Europe, although current efforts are insufficient.

•	Acknowledging that even large corporations struggle to manage PFAS risks; mid-sized firms can only mitigate risks through detailed analysis of their own products and production processes.

**Industry Support and Regulatory Environment**

•	MedTech Europe has issued a high-level position paper (position paper), but no globally harmonized solutions exist, particularly for non-European suppliers.

•	The MedTech industry proposes a 12-year phase-out period; however, some suppliers may exit the market much sooner, increasing risk.

**Needed Actions**

•	Develop clear guidance on conducting thorough supply chain and production process analyses, including best practice examples.

•	Establish a comprehensive strategy to manage PFAS risks, covering product and production chain analysis, risk mitigation, and regulatory tracking.

	


Whats up at Innofuse

Subscribe to our newsletter to stay tuned!